A genetic explanation of slaughter's concept of field cancerization: Evidence and clinical implications

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1727-1730

  Braakhuis, Boudewijn J M ^a   Tabor, Maarten P ^a   Kummer, J Alain ^a   Leemans, C René ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER; BREAST; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER GENETICS; CANCER GROWTH; CANCER LOCALIZATION; CANCER MODEL; CANCER RECURRENCE; CANCER SIZE; CARCINOGENESIS; CELL CLONE; CELL MUTANT; CELL PROLIFERATION; CHRONOSEQUENCE; COLON; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EPITHELIUM; ESOPHAGUS MUCOSA; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HEAD; HEAD AND NECK CANCER; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; LARYNX; LUNG; LUNG CANCER; MOLECULAR MODEL; MOUTH CARCINOMA; MOUTH CAVITY; MULTIPLE CANCER; NECK; OROPHARYNX; PATHOLOGICAL ANATOMY; PRECANCER; PRIORITY JOURNAL; REVIEW; SECOND CANCER; SEQUENCE ANALYSIS; SKIN; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STEM CELL; UTERINE CERVIX; VULVA;

CARCINOMA, SQUAMOUS CELL; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; RISK FACTORS;

EID: 0037446974     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Slaughter, D. P., Southwick, H. W., and Smejkal, W. "Field cancerization" in oral stratified squamous epithelium. Cancer (Phila.), 6: 963-968, 1953.
2. Copper, M. P., Braakhuis, B. J., de Vries, N., van Dongen, G. A., Nauta, J. J., and Snow, G. B. A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials. Cancer (Phila.), 71: 825-830, 1993.
3. Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., and Miller, Y. E. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogencsis. J. Clin. Invest., 100: 2133-2137, 1997.
4. Prevo, L. J., Sanchez, C. A., Galipeau, P. C., and Reid, B. J. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res., 59: 4784-4787, 1999.
5. Rosenthal, A. N., Ryan, A., Hopster, D., and Jacobs, I. J. Molecular evidence of a common clonal origin and subsequent divergent clonal evolution in vulvul intraepithelial neoplasia. vulval squamous cell carcinoma and lymph node metastases. Int. J. Cancer. 99: 549-554, 2002.
6. Chu, T. Y., Shen, C. Y., Lee, H. S., and Liu, H. S. Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer, 24: 127-134, 1999.
7. Jothy, S., Slesak, B., Harlozinska, A., Lapinska, J., Adamiak, J., and Rabczynski, J. Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression. Tumour Biol., 17: 58-64, 1996.
8. Forsti, A., Louhelainen, J., Soderberg, M., Wijkstrom, H., and Hemminki, K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur. J. Cancer, 37: 1372-1380, 2001.
9. Takahashi, T., Habuchi, T., Kakehi, Y., Mitsumori, K., Akao, T., Terachi, T., and Yoshida, O. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res., 58: 5835-5841, 1998.
10. Stern, R. S., Bolshakov, S., Nataraj, A. J., and Ananthaswamy, H. N. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. J. Investig. Dermatol., 119: 522-526. 2002.
11. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
12. Tabor, M. P., Brakenhoff, R. H., van Houten, V. M. M., Kummer, J. A., Snel, M. H. J., Snijders, P. J. F., Snow, G. B., Leemans, C. R., and Braakhuis, B. J. M. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications. Clin. Cancer Res., 7: 1523-1532, 2001.
13. Hittelman, W. N. Genetic instability in epithelial tissues at risk for cancer. Ann. N. Y. Acad. Sci., 952: 1-12, 2001.
14. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-345, 1995.
15. van Houten, V. M. M., Tabor, M. P., van den Brekel, M. W. M., Kummer, J. A., Denkers. F., Dijkstra, J., Leemans, C. R., van der Waal, I., Snow, G. B., and Brakenhoff, R. H. Mutated P53 as molecular marker for the diagnosis of head and neck cancer. J. Pathol., 198: 476-486, 2002.
16. Califano, J., Leong, P. L., Koch, W. M., Eisenberger, C. F., Sidransky, D., and Westra, W. H. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin. Cancer Res., 5: 1862-1867, 1999.
17. Tabor, M. P., van Houten. V. M. M., Kummer, J. A., Vosjan, M. J. W. D., Vlasblom, R., Snow, G. B., Leemans, C. R., Braakhuis, B. J. M., and Brakenhoff, R. H. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer, 33: 168-177, 2002.
18. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Wash. DC), 194: 23-28, 1976.
19. Tabor, M. P., Braakhuis, B. J. M., van der Wal, J. E., van Diest, P. J., Leemans, C. R., Brakenhoff, R. H., and J. A. Kummer. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J. Pathol., 199: 354-360, 2003.
20. Garcia, S. B., Park, H. S., Novelli, M., and Wright, N. A. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J. Pathol., 187: 61-81, 1999.
21. Waridel, F., Estreicher, A., Bron, L., Flaman, J. M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene, 14: 163-169, 1997.
22. Jonason, A. S., Kunala, S., Price, G. J., Restifo, R. J., Spinelli, H. M., Persing, J. A., Leffell, D. J., Tarone, R. E., and Brash, D. E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA, 93: 14025-14029, 1996.
23. Park, I. W., Wistuba, I. I., Maitra, A., Milchgrub, S., Virmani, A. K., Minna, J. D., and Gazdar, A. F. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J. Natl. Cancer Inst., 91, 1863-1868, 1999.
24. Larson, P. S., de las Morenas, A., Cupples, L. A., Huang, K., and Rosenberg, C. L. Genetically abnormal clones in histologically normal breast tissue. Am. J. Pathol., 152: 1591-1598, 1998.
25. Jones, P. H., and Watt, F. M. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 73: 713-724, 1993.
26. Tsai, Y. C., Simoneau, A. R., Spruck, C. H., Nichols, P. W., Steven, K., Buckley, J. D., and Jones, P. A. Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium. J. Urol., 153: 1697-700, 1995.
27. Linder, G., and Gartler, S. M. Distribution of glucose-6-phosphate dehydrogenase eloectrophoretic variants in different tissues of heterozygotes. Am. J. Hum. Gen., 45: 212-220, 1965.
28. Chaturvedi, V., Chu, S., Carrol, M., Brenner, J. W., and Nickoloff, B. J. Estimation of size of clonal unit for keratinocytes of normal human skin. Arch. Pathol. Lab. Med., 126: 420-424, 2002.
29. Tabor, M. P., Brakenhoff, R. H., Ruijter-Schippers, H. J., van der Wal, J. E., Snow, G. B., Leemans, C. R., and Braakhuis, B. J. M. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am. J. Pathol., 161: 1051-1060, 2002.
30. Simon, R., Eltze, E., Schafer, K. L., Burger, H., Semjonow, A., Hertle, L., Dockhom-Dworniczak, B., Terpe, H. J., and Bocker, W. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res., 61: 355-332, 2001.
31. Braakhuis, B. J. M., Tabor, M. P., Leemans, C. R., Van Der Waal, I., Snow, G. B., and Brakenhoff, R. H. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions. Head Neck, 24: 198-206, 2002.
32. Bedi, G. C., Westra, W. H., Gabrielson, E., Koch, W., and Sidransky, D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res., 56: 2484-2487, 1996.
33. Izzo, J. G., Papadimitrakopoulou, V. A., Li, X. Q., Ibarguen, H., Lee, J. S., Ro, J. Y., El-Naggar, A., Hong, W. K., and Hittelman, W. N. Dysregulated cyclin DI expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 17: 2313-2322, 1998.
34. Partridge, M., Li, S. R., Pateromichelakis, S., Francis, R., Phillips, E., Huang, X. H., Tesfa-Selase, F., and Langdon, J. D. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin. Cancer Res., 6: 2718-2725. 2000.
35. Gollin, S. M. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck, 23: 238-523, 2001.
36. Axell, T., Pindborg, J. J., Smith, C. J., and van der Waal, I. Oral white lesions with special reference to precancerous and tobacco related lesions: Conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. J. Oral Pathol. Med., 25: 49-54, 1996.
37. Schepman, K. P., van der Meij, E. H., Smeele, L. E., and van der Waal, I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol., 34: 270-275, 1998.
38. Partridge, M., Pateromichelakis, S., Phillips, E., Emilion, G. G., A'Hern, R. P., and Langdon, J. D. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res., 60: 3893-3898, 2000.
39. Rosin, M. P., Cheng, X., Poh, C., Lam, W. L., Huang, Y. Q., Lovas, J., Berean, K., Epstein, J. B., Priddy, R., Le, N. D., and Zhang, L. W. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin. Cancer Res., 6: 357-362. 2000.
40. Mao, L., Lee, J. S., Fan, Y. H., Ro, J. Y., Batsakis, J. G., Lippman, S., Hittelman, W., and Hong, W. K. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med., 2: 682-685, 1996.
41. Guo, Z., Yamaguchi, K., Sanchez-Cespedes, M., Westra, W. H., Koch, W. M., and Sidransky, D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin. Cancer Res., 7: 1963-1968, 2001.
42. Betz, C. S., Stepp, H., Janda, P., Arbogast, S., Grevers, G. Baumgartner, R., and Leunig, A. A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int. J. Cancer. 97: 245-252. 2002.
43. Cloos, J., Leemans, C. R., Van Der Sterre, M. L. T., Kuik, D. J., Snow, G. B., and Braakhuis, B. J. M. Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev., 9: 713-717, 2000.